GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Schott Pharma AG & CO KGaA (WBO:1SXP) » Definitions » Operating Cash Flow per Share

Schott Pharma AG KGaA (WBO:1SXP) Operating Cash Flow per Share : €1.22 (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Schott Pharma AG KGaA Operating Cash Flow per Share?

Schott Pharma AG KGaA's operating cash flow per share for the three months ended in Dec. 2024 was €0.16. Schott Pharma AG KGaA's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2024 was €1.22.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Schott Pharma AG KGaA was -16.00% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 19.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Schott Pharma AG KGaA's Operating Cash Flow per Share or its related term are showing as below:

WBO:1SXP' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: 19.4   Med: 19.85   Max: 20.3
Current: 19.4

During the past 5 years, Schott Pharma AG KGaA's highest 3-Year average Operating Cash Flow per Share Growth Rate was 20.30% per year. The lowest was 19.40% per year. And the median was 19.85% per year.

WBO:1SXP's 3-Year OCF Growth Rate is ranked better than
65.52% of 696 companies
in the Medical Devices & Instruments industry
Industry Median: 8.25 vs WBO:1SXP: 19.40

Schott Pharma AG KGaA Operating Cash Flow per Share Historical Data

The historical data trend for Schott Pharma AG KGaA's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Schott Pharma AG KGaA Operating Cash Flow per Share Chart

Schott Pharma AG KGaA Annual Data
Trend Sep20 Sep21 Sep22 Sep23 Sep24
Operating Cash Flow per Share
0.69 0.88 1.21 1.21 1.50

Schott Pharma AG KGaA Quarterly Data
Sep20 Sep21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.43 0.17 0.39 0.50 0.16

Competitive Comparison of Schott Pharma AG KGaA's Operating Cash Flow per Share

For the Medical Instruments & Supplies subindustry, Schott Pharma AG KGaA's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Schott Pharma AG KGaA's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Schott Pharma AG KGaA's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Schott Pharma AG KGaA's Price-to-Operating-Cash-Flow falls into.


;
;

Schott Pharma AG KGaA Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Schott Pharma AG KGaA's Operating Cash Flow per Share for the fiscal year that ended in Sep. 2024 is calculated as

Operating Cash Flow per Share (A: Sep. 2024 )=Cash Flow from Operations (A: Sep. 2024 )/Shares Outstanding (Diluted Average) (A: Sep. 2024 )
=225.326/150.615
=1.50

Schott Pharma AG KGaA's Operating Cash Flow per Share for the quarter that ended in Sep. 2024 is calculated as

Operating Cash Flow per Share (Q: Dec. 2024 )=Cash Flow from Operations (Q: Dec. 2024 )/Shares Outstanding (Diluted Average) (Q: Dec. 2024 )
=24.374/152.074
=0.16

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Schott Pharma AG KGaA Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Schott Pharma AG KGaA's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Schott Pharma AG KGaA Business Description

Traded in Other Exchanges
Address
Hattenbergstrasse 10, Mainz, RP, DEU, 55122
Schott Pharma AG & CO KGaA caters to the pharma, biotech and life science industry by providing containment solutions and delivery systems for injectable drugs. Its segments include; Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of the revenue is generated from Drug Containment Solutions segment which includes products like vials, cartridges and ampoules for safe drug containment. Geographically, the company generates revenue from Europe, Middle East, Africa (EMEA), Asia and South Pacific, North America and South America.

Schott Pharma AG KGaA Headlines

No Headlines